These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31307918)

  • 1. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
    Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Progression of Midbrain Atrophy in Parkinsonism: Longitudinal MRI Study.
    Hwang M; Yang H; Kim Y; Youn J; Park J; Huh YE; Kim HT; Cho JW
    Neurodegener Dis; 2017; 17(1):31-37. PubMed ID: 27614955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.
    Quattrone A; Caligiuri ME; Morelli M; Nigro S; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Vaccaro MG; Sabatini U; Vescio V; Stanà C; Rocca F; Caracciolo M; Quattrone A
    Parkinsonism Relat Disord; 2019 Jun; 63():124-130. PubMed ID: 30803901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Longoni G; Agosta F; Kostić VS; Stojković T; Pagani E; Stošić-Opinćal T; Filippi M
    Mov Disord; 2011 Feb; 26(2):247-55. PubMed ID: 21412831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midbrain morphology in idiopathic normal pressure hydrocephalus: A progressive supranuclear palsy mimic.
    Constantinides VC; Paraskevas GP; Velonakis G; Toulas P; Stefanis L; Kapaki E
    Acta Neurol Scand; 2020 Apr; 141(4):328-334. PubMed ID: 31856297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
    Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.
    Morelli M; Arabia G; Messina D; Vescio B; Salsone M; Chiriaco C; Perrotta P; Rocca F; Cascini GL; Barbagallo G; Nigro S; Quattrone A
    Mov Disord; 2014 Apr; 29(4):488-95. PubMed ID: 24573655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of MRI parameters in pure akinesia with gait freezing.
    Nakahara K; Nakane S; Kitajima M; Masuda-Narita T; Matsuo H; Ando Y
    J Neurol; 2020 Mar; 267(3):752-759. PubMed ID: 31745723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
    Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A
    Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and reliable MRI diagnosis for progressive supranuclear palsy.
    Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
    Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy.
    Luca A; Nicoletti A; Donzuso G; Terravecchia C; Cicero CE; D'Agate C; Rascuná C; Manna R; Mostile G; Zappia M
    J Alzheimers Dis; 2021; 80(4):1669-1674. PubMed ID: 33720901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.
    Cosottini M; Ceravolo R; Faggioni L; Lazzarotti G; Michelassi MC; Bonuccelli U; Murri L; Bartolozzi C
    Acta Neurol Scand; 2007 Jul; 116(1):37-42. PubMed ID: 17587253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Utility of Tectal Plate Measurements on Magnetic Resonance Imaging in Progressive Supranuclear Palsy.
    Amrami A; Singh NA; Ali F; Pham NTT; Stephens YC; Josephs KA; Whitwell JL
    Mov Disord; 2024 Aug; 39(8):1402-1407. PubMed ID: 38586905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.
    Albrecht F; Bisenius S; Neumann J; Whitwell J; Schroeter ML
    Neuroimage Clin; 2019; 22():101722. PubMed ID: 30831462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.